This recombinant construct is made from an Affibody with previously proven high affinity against B7-H3 (Oroujeni et al., 2023) linked to Magainin-2, a potent cytotoxic membranolytic peptide, with proven cancer cell-killing properties (Lehmann et al., 2006). The gene discussed is CD276; the disease is cancer.